Key facts
- Notable investors include Zhongyiren Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for High Precision Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for High Precision Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About High Precision Medicine
Developer of advanced genomic and biomedical technology software designed to enhance precision medicine research and clinical diagnostics. The company offers high-throughput sequencing, bioinformatics platforms, and stem cell applications, enabling healthcare institutions and research organizations to achieve accurate disease insights and personalized therapeutic strategies.
- Sector
- Healthcare
- HQ
- Huzhou, China
- Founded
- 2023
- Employees
- 3
- Ownership
- Privately Held (backing)
High Precision Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in High Precision Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on High Precision Medicine in its N-PORT filings yet. We sweep new filings monthly.